Riskpilot← Back to searchSign inGet full accessCASMED AS
ASActiveOrg 922155631Bølehøgda 38A, 3746 SkienOther human health activities n.e.c. · NACE 8699Est. 20194 employees
Revenue 2024
NOK 3,4M
-26% vs 2023
EBITDA margin
19.2%
-81% vs 2023
Equity ratio
2.7%
Financial strength
Net profit 2024
NOK 4,7M
-30% vs 2023
| Revenue | NOK 3,4M | -26% |
| EBITDA | NOK 646K | -81% |
| Net profit | NOK 4,7M | -30% |
| Total assets | NOK 7,5M | -23% |
| Equity | NOK 204K | -77% |
| Employees | 4 | — |
Legal name
CASMED AS
Org number
922155631
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
2. februar 2019
Share capital
NOK 30 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Levere helsetjenester, eiendomsforvaltning samt relaterte virksomheter.
Address
Bølehøgda 38A, 3746 Skien
Email
sales@casmed.co.uk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 598 | 5 794 | 1 016 | 4 518 | 3 360 |
| Staff expenses | −1 355 | −1 196 | −875 | −1 026 | −1 152 |
| EBITDA | 2 048 | 4 369 | −250 | 3 330 | 646 |
| Depreciation & amort. | −67 | −67 | −67 | −67 | −125 |
| EBIT | 1 980 | 4 301 | −318 | 3 263 | 521 |
| Net financials | 100 | 35 | 4 274 | 5 264 | 5 006 |
| Profit before tax | 2 080 | 4 336 | 3 956 | 8 527 | 5 527 |
| Tax | 460 | 970 | 887 | 1 894 | 873 |
| Net profit | 1 620 | 3 365 | 3 070 | 6 633 | 4 653 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 151 | 3 318 | 5 240 | 9 678 | 7 474 |
| Equity | 491 | 787 | 815 | 888 | 204 |
| Long-term debt | 527 | 100 | 116 | 125 | 575 |
| Short-term debt | 2 132 | 2 431 | 4 309 | 8 664 | 6 695 |
| Total debt | 2 659 | 2 531 | 4 425 | 8 790 | 7 270 |
EBITDA margin
19.2%
This company
15.8%
Market median
+22% vs market
20202024
Equity ratio
2.7%
This company
38.2%
Market median
-93% vs market
20202024
Return on equity
2277.0%
This company
18.4%
Market median
+12275% vs market
20202024
Net profit margin
138.5%
This company
8.1%
Market median
+1610% vs market
20202024
Asset turnover
0.45×
This company
1.12×
Market median
-60% vs market
20202024
Debt / equity
35.57×
This company
0.62×
Market median
-5637% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CH Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Casper Holmberg Holding As
CASMED AS Board members of CASMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Casper Holmberg | Chief Executive Officer | 0 companies |
| Line Holmberg | Board of Directors | 0 companies |